Watchlist Price Alert

Landos Biopharma Inc. (LABP)

NASDAQ: LABP · Real-Time Price · USD

22.93

0.13 (0.57%)

At close: May 23, 2024, 8:00 PM

Landos Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	29.05M	37.55M	42.41M	44.05M	45.24M	36.64M	28.88M	19.24M	11.29M	8.3M	17.89M	18.69M	8.57M	2.42M	2.48M	9.81M
Short-Term Investments	n/a	n/a	62K	687K	4.76M	7.76M	19.11M	36.51M	62.51M	82.58M	84.78M	96.44M	97.79M	25.72M	32.85M	40.16M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27K	26K	n/a	n/a	n/a	n/a	837K	11K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3K	2K	1K	154K	113K	1K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.4M	n/a	n/a
Other Current Assets	842K	491K	710K	1.55M	1.18M	851K	1.5M	2.29M	3.56M	1.27M	1.65M	2.6M	3.39M	202K	133K	144K
Total Current Assets	29.9M	38.04M	43.23M	46.28M	51.18M	45.25M	49.49M	58.04M	77.36M	92.15M	104.32M	117.73M	109.75M	29.89M	35.58M	50.11M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	224K	707K	780K	564K	465K	444K	348K	359K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	251K	733K	780K	564K	465K	444K	1.19M	370K
Total Assets	29.9M	38.04M	43.23M	46.28M	51.18M	45.25M	49.49M	58.04M	77.61M	92.88M	105.1M	118.29M	110.21M	30.33M	36.76M	50.48M
Account Payables	1.56M	1.38M	1.14M	1.03M	2.3M	3.44M	3.2M	4.71M	9.8M	12.91M	10.11M	10.69M	8.2M	8.61M	6.65M	2.05M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5.18M	4.87M	4.43M	1.99M	1.86M	2.69M	2.27M	1.8M	5.68M	3.7M	981K	1.84M	619K	2.43M	1.31M	978K
Total Current Liabilities	6.74M	6.25M	5.57M	3.02M	4.16M	6.12M	5.47M	6.51M	15.51M	16.61M	11.1M	12.53M	8.82M	11.03M	7.96M	3.03M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	85K	149K	212K	73.31M	73.04M	73.04M
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	2.3M	3.44M	3.2M	4.71M	9.83M	12.91M	85K	149K	212K	73.31M	73.04M	73.04M
Total Liabilities	6.74M	6.25M	5.57M	3.02M	4.16M	6.12M	5.47M	6.51M	15.51M	16.61M	11.18M	12.68M	9.03M	84.35M	81M	76.06M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	31K	31K	31K	31K	312K	403K	403K	403K	403K	403K	401K	399K	399K	71K	67K	63K
Retained Earnings	-164.26M	-155.36M	-149.24M	-143.38M	-139.46M	-133.43M	-128.19M	-120.3M	-109.02M	-94.15M	-74.05M	-61.45M	-65.55M	-55.73M	-44.39M	-25.59M
Comprehensive Income	n/a	n/a	-1K	-7K	79K	-57K	-211K	-392K	-467K	-225K	131K	-142K	-102K	10K	36K	-77K
Shareholders Equity	23.15M	31.79M	37.66M	43.27M	47.02M	39.13M	44.01M	51.53M	62.1M	76.27M	93.92M	105.61M	101.18M	-54.02M	-44.23M	-25.58M
Total Investments	n/a	n/a	62K	687K	4.76M	7.76M	19.11M	36.51M	62.51M	82.58M	84.78M	96.44M	97.79M	25.72M	32.85M	40.16M